Kennedy Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Kennedy Capital Management's ROIV Position: Q3 2026 in Review
Kennedy Capital Management increased its Roivant Sciences (ROIV) stake by 7.8% in Q3 2026, buying an estimated $462K and bringing the position to 176,470 shares worth $6.45M. The position accounts for 0.12% of the portfolio, ranked #276.
Kennedy Capital Management first reported a position in ROIV in Q1 2024 and has held it in 11 quarters since. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Kennedy Capital Management held 176,470 shares of Roivant Sciences worth $6.45M as of Q3 2026.
- Kennedy Capital Management bought 12,733 Roivant Sciences shares in Q3 2026, an estimated $462K.
- Roivant Sciences made up 0.12% of Kennedy Capital Management's portfolio in Q3 2026, its #276 holding.
- Kennedy Capital Management first reported a position in Roivant Sciences in Q1 2024 and has held it in 11 quarters since.
- 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Kennedy Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.